Functional assessments demonstrated that while both the DAP12-containing CAR and its predecessors exhibited comparable tumor-killing, the DAP12 construct produced lower levels of IFNγ, TNFα, and IL-2, during tumor cell lysis (104). The gene discussed is IFNG; the disease is neoplasm.